Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2271-2280 of 2760 for cancer

Edit search filters
  1. Early pancreatic cancer detection

    Jacksonville, FL

  2. Pencil Beam Scanning Proton Radiotherapy for Esophageal Cancer

    Rochester, MN

  3. Outcomes Database To ProspectivelY ASSEss The Changing TherapY Landscape In Renal Cell Carcinoma (ODYSSEY RCC)

    Rochester, MN

  4. A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

    Scottsdale/Phoenix, AZ

  5. Gastrointestinal-Related Cancers and Diseases

    Rochester, MN

  6. A Study to Assess Endometrial Cancer Recurrence in Patients After 36 Months

    Rochester, MN

  7. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

  8. Alpha-1 AD Carriers and Lung Cancer Risk

    Rochester, MN

  9. Cardio-Oncology Clinic Registry

    Rochester, MN

  10. A Study to Better Understand How to Predict and Manage Patients Who are at High Risk for Developing Rheumatic Immune-related Adverse Events While Receiving Treatment for Melanoma

    Rochester, MN

.

Mayo Clinic Footer